Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 2.78 M3.11 M3.07 M3.55 M3.91 M 13.63 M Research & development ————— — Operating income -2.39 M-3.4 M304 K1.69 M-4.55 M -5.96 M Non-Operating Income, Total -3.19 M-757 K11.65 M890 K-33 K 11.75 M Interest expense, net of interest capitalized 1.39 M759 K250 K1.65 M174 K 2.83 M Non-Operating Income, excl. Interest Expenses -3.19 M-757 K11.65 M890 K-33 K 11.75 M Unusual income/expense ————— — Pretax income -5.57 M-4.15 M11.96 M2.58 M-4.58 M 5.8 M Equity in earnings ————— — Taxes -10 K-34 K0-435 K0 -469 K Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -5.56 M-4.12 M11.96 M3.01 M-4.58 M 6.27 M Discontinued operations ————— — Net income -5.56 M-4.12 M11.96 M3.01 M-4.58 M 6.27 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -5.56 M-4.12 M11.96 M3.01 M-4.58 M 6.27 M Basic earnings per share (Basic EPS) -0.4-0.270.760.26-0.29 0.46 Diluted earnings per share (Diluted EPS) -0.4-0.270.750.26-0.29 0.45 Average basic shares outstanding 13.94 M15.25 M15.66 M15.16 M15.96 M — Diluted shares outstanding 13.94 M15.25 M15.89 M15.34 M15.96 M — EBITDA -2.01 M-4.17 M1.97 M10.73 M-5.83 M 2.7 M EBIT -5.3 M-6.72 M-1.03 M8.23 M-8.53 M -8.04 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 3.02 M2.54 M3 M2.5 M2.7 M 10.74 M